Orthofix to Report Third Quarter 2026 Financial Results
Orthofix Medical (OFIX) will release its third quarter 2026 financial results on November 9, 2026, before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Company to Host Conference Call on Monday, November 9, 2026, at 8:30 am Eastern Time
Interested parties may access the conference call by dialing 833-461-5787 in the
Internet Posting of Information
Orthofix regularly shares important updates in the “Investors” section of its website at Orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.
About Orthofix
Orthofix is a global medical technology company dedicated to advancing healing and restoring mobility for patients with complex musculoskeletal conditions. Headquartered in Lewisville, Texas, the Company offers a differentiated portfolio of spinal implants, therapeutic solutions, limb reconstruction systems, biologics and enabling technologies, including the 7D FLASH™ Navigation System. Orthofix’s technology-enabled solutions are designed to support surgeons across the continuum of care and improve outcomes for patients. Learn more at Orthofix.com and follow Orthofix on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261023041671/en/
Investors and Media
Julie Dewey, IRC
Chief Investor Relations & Communications Officer
JulieDewey@Orthofix.com
+1 209.613.6945
Source: Orthofix Medical Inc.